NewPrinces S.p.A. has acquired the Italian infant and specialty food business of Heinz Italia S.p.A., enhancing its market position with brands like Plasmon and Nipiol.

Information on the Target

NewPrinces S.p.A. has successfully acquired the Italian infant and specialty food business of Heinz Italia S.p.A. This acquisition includes renowned infant food brands such as Plasmon, Nipiol, and Dieterba, as well as medical nutrition brands Aproten and Biaglut. The deal encompasses Heinz's production facility located in Latina, which employs approximately 300 staff members and has the capacity to manufacture about 1.8 billion biscuits annually for the Plasmon brand. The financial impact of the acquired assets is significant, with the acquisition perimeter generating revenues close to €170 million and an EBITDA of €17 million projected for 2024. The completion of this transaction is anticipated by the end of 2025, pending necessary regulatory approvals.

Industry Overview in Italy

The baby food and specialty nutrition market in Italy is characterized by robust growth and fierce competition. With its rich culinary heritage and increasing health consciousness among parents, Italy boasts a thriving sector for infant and specialty foods that exceeds €1 billion annually. The industry is driven by key players committed to product innovation and quality, providing a plethora of options tailored to diverse consumer needs.

Notably, Plasmon stands at the forefront of this market, holding the status of the top baby food brand in Italy, claiming roughly 24% of the market share. Its dominance is highlighted by a staggering 73% share in